Showing results (121-130 of 163) with videos related to

Sort By:
Pageof 17
Blood|September 22, 2010
Inherited genetic susceptibility to monoclonal B-cell lymphocytosisDalemari Crowther-Swanepoel, Tanguy Corre, Amy Lloyd, et al.
Cancer Research|March 12, 2016
Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung CancerNichola Johnson, Paolo De Ieso, Gabriele Migliorini, et al.
Blood|October 23, 2012
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trialDavid G Oscier, Matthew J J Rose-Zerilli, Nils Winkelmann, et al.
Haematologica|August 24, 2011
Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failedAmr R Ibrahim, Richard E Clark, Tessa L Holyoake, et al.
American Journal of Human Genetics|August 5, 2005
A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility lociGabrielle S Sellick, Emily L Webb, Ruth Allinson, et al.
Blood|December 17, 2011
Responses to second-line tyrosine kinase inhibitors are durable: an intention-to-treat analysis in chronic myeloid leukemia patientsDragana Milojkovic, Jane F Apperley, Gareth Gerrard, et al.
Blood|November 26, 2010
Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observationMauricette Michallet, Peter Dreger, Laurent Sutton, et al.
Haematologica|March 4, 2014
ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trialMatthew J J Rose-Zerilli, Jade Forster, Helen Parker, et al.
British Journal of Haematology|May 11, 2011
Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia riskDalemari Crowther-Swanepoel, Maria Chiara Di Bernardo, Krzysztof Jamroziak, et al.
Blood|October 17, 2013
CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemiaGillian G Johnson, Ke Lin, Trevor F Cox, et al.
Pageof 17